BRII-297

N/A

Report date: 2023/06/01 14:11:13
NME

Base Information

Drug NameBRII-297
Drug Alias NameBRII-297
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor modulatorsprotein allosteric modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsDepressionDepression, Postpartum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesBrii Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesBrii Biosciences (Shanghai) Co LtdBrii Biosciences Inc
Inactive CompaniesN/A
Active IndicationsDepressionDepression, Postpartum
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A